Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 3.270
+0.010 (0.31%)
Aug 12, 2026, 4:11 PM AEST
Mayne Pharma Group Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 265 | 406 | 383 | 367 | 441 | 565 | |
Market Cap Growth | -34.67% | 6.16% | 4.25% | -16.81% | -21.88% | -12.64% |
Enterprise Value | 240 | 321 | 264 | 273 | 717 | 791 |
Last Close Price | 3.26 | 5.00 | 4.71 | 4.40 | 4.40 | 5.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | - | 3.13 | - | - |
Forward PE | - | 150.33 | 150.33 | 150.33 | 150.33 | 150.33 |
PS Ratio | 0.65 | 1.00 | 0.99 | 2.00 | 2.81 | 1.41 |
PB Ratio | 0.75 | 1.10 | 0.84 | 0.58 | 0.82 | 0.73 |
P/TBV Ratio | - | - | - | 19.18 | 3.46 | - |
P/FCF Ratio | 17.73 | 78.23 | - | - | - | 13.52 |
P/OCF Ratio | 12.23 | 23.25 | - | - | - | 9.59 |
PEG Ratio | - | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 0.59 | 0.79 | 0.68 | 1.49 | 4.56 | 1.97 |
EV/EBITDA Ratio | 7.93 | 7.63 | - | - | - | 15.81 |
EV/FCF Ratio | 16.06 | 61.85 | - | - | - | 18.94 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.12 | 0.11 | 0.09 | 0.08 | 0.77 | 0.45 |
Debt / EBITDA Ratio | 1.40 | 0.90 | - | - | - | 6.53 |
Debt / FCF Ratio | 2.84 | 7.95 | - | - | - | 8.33 |
Net Debt / Equity Ratio | -0.07 | -0.16 | -0.24 | -0.27 | 0.59 | 0.32 |
Net Debt / EBITDA Ratio | -0.93 | -1.40 | 7.62 | 1.48 | -6.81 | 4.99 |
Net Debt / FCF Ratio | -1.67 | -11.39 | 4.75 | 3.38 | -18.34 | 5.98 |
Asset Turnover | 0.39 | 0.38 | 0.33 | 0.14 | 0.11 | 0.24 |
Inventory Turnover | 2.80 | 2.57 | 2.16 | 1.05 | 0.81 | 2.23 |
Quick Ratio | 1.01 | 1.08 | 1.03 | 1.38 | 0.61 | 1.31 |
Current Ratio | 1.33 | 1.35 | 1.33 | 1.78 | 0.81 | 1.87 |
Return on Equity (ROE) | -20.58% | -21.85% | -30.98% | -54.14% | -33.61% | -23.05% |
Return on Assets (ROA) | -2.30% | -1.28% | -4.07% | -9.04% | -5.57% | -0.47% |
Return on Invested Capital (ROIC) | -11.65% | -6.73% | -19.33% | -27.89% | -13.07% | -1.07% |
Return on Capital Employed (ROCE) | -5.60% | -2.90% | -9.80% | -19.60% | -18.60% | -1.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -31.42% | -23.10% | -45.53% | 31.94% | -63.75% | -36.91% |
FCF Yield | 5.64% | 1.28% | -6.08% | -13.91% | -3.90% | 7.40% |
Payout Ratio | - | - | - | 38.63% | - | - |
Buyback Yield / Dilution | -0.43% | 0.60% | 3.11% | 0.15% | -4.74% | -2.75% |